Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-21-065246
Filing Date
2021-12-14
Accepted
2021-12-14 17:18:30
Documents
50
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2020a1_helixacquisition.htm 10-K/A 712663
2 DESCRIPTION OF SECURITIES f10k2020a1ex4-5_helixacq.htm EX-4.5 96108
3 CERTIFICATION f10k2020a1ex31-1_helixacq.htm EX-31.1 11592
4 CERTIFICATION f10k2020a1ex31-2_helixacq.htm EX-31.2 11062
5 CERTIFICATION f10k2020a1ex32-1_helixacq.htm EX-32.1 4264
6 CERTIFICATION f10k2020a1ex32-2_helixacq.htm EX-32.2 4038
  Complete submission text file 0001213900-21-065246.txt   2651712

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE hlxa-20201231.xml EX-101.INS 229805
8 XBRL SCHEMA FILE hlxa-20201231.xsd EX-101.SCH 36842
9 XBRL CALCULATION FILE hlxa-20201231_cal.xml EX-101.CAL 15347
10 XBRL DEFINITION FILE hlxa-20201231_def.xml EX-101.DEF 152128
11 XBRL LABEL FILE hlxa-20201231_lab.xml EX-101.LAB 252244
12 XBRL PRESENTATION FILE hlxa-20201231_pre.xml EX-101.PRE 155796
Mailing Address C/O CORMORANT ASSET MANAGEMENT, LLP 200 CLARENDON STREET FL 52 BOSTON MA 02116
Business Address C/O CORMORANT ASSET MANAGEMENT, LLP 200 CLARENDON STREET FL 52 BOSTON MA 02116 857 702 0370
Helix Acquisition Corp (Filer) CIK: 0001821586 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39630 | Film No.: 211491952
SIC: 2834 Pharmaceutical Preparations